세계의 정밀 영양 시장 예측(-2029년) : 기술별, 용도별, 서비스 유형별, 최종 용도별, 보충제별, 지역별

The global market for precision nutrition is estimated to be valued at USD 6.09 billion in 2024 and is projected to reach USD 12.89 billion by 2029, at a CAGR of 16.2% during the forecast period. Precision nutrition is shaping the industry by incorporating AI, bringing with it the possibility of very individualized and data-driven health solutions. AI-powered platforms can analyze complex datasets, which incorporate genetic, microbiome, and lifestyle information, allowing for the provision of tailored dietary recommendations and health plans. Technological innovations in nutrition are improving the accuracy of nutrient insights, cutting the intricacy of data interpretation, and making product innovation easier. As a consequence, AI is driving efficiency, scalability, and accessibility in precision nutrition to make personalized health solutions more precise and broadly available.

ZOE Limited (UK) offers a personal food quality score that is determined using advanced AI-driven insights, powered by ongoing PREDICT studies. The food quality scores predict the effect of a particular food on an individual's dietary inflammation and gut health, making personalized recommendations for diet. Similarly, Viome Life Sciences, Inc (US) utilizes AI in combination with mRNA sequencing to decipher vast mountains of microbiome data. Such a method turns complex biological information into sharp health scores, providing personalized recommendations to foods, vitamins, supplements, as well as other nutrients that enhance one's health.

Disruption in the precision nutrition market: The precision nutrition market is experiencing significant disruptions driven by advancements in technology, increasing consumer awareness, and evolving healthcare approaches. Companies are leveraging AI, genetic testing, and microbiome analysis to deliver personalized nutrition solutions, transforming traditional dietary practices. This shift is reshaping how individuals manage health and wellness. Technological advancements, greater consumer awareness, and health care changing approaches are bringing about unprecedented disruptions to the precision nutrition market. Some of the key disruptions in the precision nutrition market include:

• Advances in Genomics and Microbiome Research: Technologies like mRNA sequencing are enabling deeper insights into gut health and genetic predispositions, driving innovation in tailored health solutions.
• Real-Time Analytics and Feedback: Innovations in data analytics allow consumers to receive instant feedback on dietary choices, empowering them to make informed health decisions.
• Integration with Lifestyle Apps: Precision nutrition platforms are being integrated with fitness and mental health apps, offering a comprehensive approach to health management.

"The direct-to-consumer segment holds the highest share in the end-use segment of precision nutrition market."

The DTC segment currently rules the roost in the precision nutrition market as demand increases for tailored, preventive healthcare solutions, with this segment very actively leveraging technological advancements in AI, genomics, and microbiome research, providing such tailor-made dietary and supplement recommendations through easy-to-use platforms. At-home DNA, microbiome, and metabolic health test kits have become popular because most of them are offered by brands such as ZOE, Viome, and 23andMe, and bring instant convenience to access health insights through such platforms without having to visit clinics or laboratories.

Subscription-based models and digital platforms drive engagement even further by delivering live health monitoring, changing meal plans, and nutrition consultation. The DTC approach resonates especially with the more health-conscious consumers who seek actionable, data-driven insights that enable them to optimize their well-being. Additionally, seamless integration with wearable devices and apps allows users to follow real-time health metrics, making the appeal of personalized nutrition even more significant. Conclusively, the upscaling of testing kits in terms of affordability, as well as deepening internet penetration, has reached the emerging markets. Therefore, DTC continues to gain precedence over traditional healthcare channels: this segment is the biggest and also growing faster than any other segment, with precision nutrition.

"The general health & wellness segment is projected to hold a significant market share in the application segment during the forecast period."

The General Health & Wellness segment is important in the precision nutrition market and is anticipated to continue to grow, driven by increasing focus on holistic well-being and preventive health. This segment caters to consumers seeking an improvement in the overall quality of life through personalized dietary solutions, supplements, and functional foods. With more chronic cases, such as obesity and diabetes, the need to raise the bar for precision nutrition for that specific population segment is also on the rise. Finally, with more focus on immunity and healthy living in the long term, the wellness programs naturally find greater interest in personalization. Exercise apps and wearables have added numerous solutions in this space, making it possible for consumers to track in real-time their progress and adjust their regimen. As the average consumer becomes more proactive about maintaining a healthy lifestyle, it is indeed growth within the General Health & Wellness segment that drives the precise nutrition industry forward-that catalyst for the sector.

North America is expected to hold highest share in the precision nutrition market.

North America dominates the precision nutrition market, supported by the great health care infrastructure and awareness among consumers as well as the widespread adoption of personalized health solutions in the region. The key players have intensified their presence in the region with innovation in at-home test kits and AI-driven recommendations through companies such as Viome, ZOE, and 23andMe. Improving health awareness and associated chronic conditions, such as obesity and diabetes, have increased demand for individualized nutritional plans. Investment in genomics and microbiome research has also been significant along with wearable devices and digital platforms that create ease of accessibility and deepen customer engagement. North America continues to be the early adopter of technological innovations and thus has a supporting regulatory environment that remains in its favor to remain the market leader for precision nutrition.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the precision nutrition market:

• By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
• By Designation: Directors - 20%, Managers - 50%, Others- 30%
• By Region: North America - 25%, Europe - 30%, Asia Pacific - 20%, South America - 15% and Rest of the World -10%

Prominent companies in the market include Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia) , 23andMe, Inc. (US), DayTwo Inc (US), Nutrigenomix (Canada), Genesis Healthcare Co. (Japan), AMILI (Singapore), SelfDecode (US), Genequest Inc. (Japan), Ajinomoto Co., Inc. (Japan), Thorne (US), DNAlysis (South Africa), and Xcode Life (US).

Other players include GenoPalate Inc (US), LifeNome Inc. (US), Century Genomics Limited (UK), Sun Genomics (US), Metagen, Inc. (Japan), Segterra, Inc. (US), GeneusDNA (Thailand), Holifya S.r.l. (Italy), GX Sciences, LLC (US), and Nutrisense (US).

Research Coverage:

This research report categorizes the precision nutrition market by technology (metabolomics, genomics, transcriptomics, proteomics and others), service type (genomics and multi-omics analysis services, personalized plans & subscription services, consultation services, digital platforms & solutions, and institutional and wellness programs), end use (healthcare providers, direct-to-consumer, fitness & wellness companies, research institutes, and dietary supplement manufacturers), application (disease management, weight management, general health & wellness, and sports nutrition), supplements (vitamins, minerals, probiotics, herbal supplements, protein supplements, amino acids, enzymes, and other supplements) and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of precision nutrition market. A detailed analysis of the key industry players has been done to provide insights into their business overview, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments associated with the precision nutrition market. Competitive analysis of upcoming startups in the precision nutrition market ecosystem is covered in this report. Furthermore, industry-specific trends such as technology analysis, ecosystem and market mapping, patent, regulatory landscape, among others, are also covered in the study.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall precision nutrition and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (rising non communicable diseases), restraints (high costs of testing), opportunities (integration of AI and big data analytics) and challenges (privacy and security concerns) influencing the growth of the precision nutrition market.
• New product launch/Innovation: Detailed insights on research & development activities and new product launches in the precision nutrition market.
• Market Development: Comprehensive information about lucrative markets - the report analyzes the precision nutrition market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the precision nutrition market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product foot prints of leading players such as Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia), 23andMe, Inc. (US), DayTwo Inc (US), and other players in the precision nutrition market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
• 1.4 YEARS CONSIDERED
• 1.5 UNIT CONSIDERED
  • 1.5.1 CURRENCY/VALUE UNIT
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
    • 2.2.2.1 Approach to estimate market size using top-down analysis
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PRECISION NUTRITION MARKET
• 4.2 NORTH AMERICA: PRECISION NUTRITION MARKET, BY APPLICATION AND COUNTRY
• 4.3 PRECISION NUTRITION MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
• 4.4 PRECISION NUTRITION MARKET, BY TECHNOLOGY AND REGION
• 4.5 PRECISION NUTRITION MARKET, BY SERVICE TYPE AND REGION
• 4.6 PRECISION NUTRITION MARKET, BY SUPPLEMENT AND REGION
• 4.7 PRECISION NUTRITION MARKET, BY APPLICATION AND REGION
• 4.8 PRECISION NUTRITION MARKET, BY END USE AND REGION

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 INCREASE IN HEALTHCARE EXPENDITURES
  • 5.2.2 INCREASE IN GLOBAL GDP
• 5.3 MARKET DYNAMICS
  • 5.3.1 DRIVERS
    • 5.3.1.1 Growing awareness of personalized health
    • 5.3.1.2 Boom in global wellness economy
    • 5.3.1.3 Rise in non-communicable diseases
  • 5.3.2 RESTRAINTS
    • 5.3.2.1 High cost of precision nutrition solutions
    • 5.3.2.2 Lack of standardization and comprehensive scientific validation
  • 5.3.3 OPPORTUNITIES
    • 5.3.3.1 Integration of AI and big data analytics
    • 5.3.3.2 Rising adoption of digital health tools
  • 5.3.4 CHALLENGES
    • 5.3.4.1 Privacy and data security concerns
    • 5.3.4.2 Addressing consumer skepticism
• 5.4 IMPACT OF AI/GEN AI ON PRECISION NUTRITION MARKET
  • 5.4.1 INTRODUCTION
  • 5.4.2 USE OF GEN AI IN PRECISION NUTRITION
  • 5.4.3 CASE STUDY ANALYSIS
    • 5.4.3.1 Transforming personalized nutrition with Nutrigenomix
    • 5.4.3.2 IBM Watson and PathAI's impact on specialized healthcare

6 INDUSTRY TRENDS

• 6.1 INTRODUCTION
• 6.2 VALUE CHAIN ANALYSIS
  • 6.2.1 DATA COLLECTION
  • 6.2.2 DATA ANALYSIS AND RECOMMENDATION
  • 6.2.3 CUSTOMIZED NUTRITION SOLUTIONS
  • 6.2.4 PRODUCT DELIVERY
• 6.3 TRADE ANALYSIS
  • 6.3.1 EXPORT SCENARIO OF HS CODE 3822
  • 6.3.2 IMPORT SCENARIO OF HS CODE 3822
• 6.4 TECHNOLOGY ANALYSIS
  • 6.4.1 KEY TECHNOLOGIES
    • 6.4.1.1 Artificial intelligence and machine learning
  • 6.4.2 COMPLEMENTARY TECHNOLOGIES
    • 6.4.2.1 Advanced imaging and biosensors
  • 6.4.3 ADJACENT TECHNOLOGIES
    • 6.4.3.1 Virtual health platforms and telemedicine
• 6.5 PRICING ANALYSIS
  • 6.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY GENOMICS AND MULTI-OMICS ANALYSIS SERVICES
• 6.6 ECOSYSTEM ANALYSIS
  • 6.6.1 DEMAND-SIDE
  • 6.6.2 SUPPLY-SIDE
• 6.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 6.8 PATENT ANALYSIS
• 6.9 KEY CONFERENCES AND EVENTS, 2024-2025
• 6.10 REGULATORY LANDSCAPE
  • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.10.2 NORTH AMERICA
    • 6.10.2.1 US
    • 6.10.2.2 Canada
    • 6.10.2.3 Mexico
  • 6.10.3 EUROPE
    • 6.10.3.1 European Union Regulations
      • 6.10.3.1.1 Processing of personal data
      • 6.10.3.1.2 Borderline products
      • 6.10.3.1.3 Nutrition & health claims
  • 6.10.4 ASIA PACIFIC
    • 6.10.4.1 China
    • 6.10.4.2 India
    • 6.10.4.3 Australia & New Zealand
  • 6.10.5 SOUTH AMERICA
    • 6.10.5.1 Brazil
    • 6.10.5.2 Argentina
• 6.11 PORTER'S FIVE FORCES ANALYSIS
  • 6.11.1 INTENSITY OF COMPETITIVE RIVALRY
  • 6.11.2 BARGAINING POWER OF SUPPLIERS
  • 6.11.3 BARGAINING POWER OF BUYERS
  • 6.11.4 THREAT OF SUBSTITUTES
  • 6.11.5 THREAT OF NEW ENTRANTS
• 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.12.2 BUYING CRITERIA
• 6.13 CASE STUDY ANALYSIS
  • 6.13.1 LAUNCH OF 23ANDME+ TOTAL HEALTH MEMBERSHIP
  • 6.13.2 GENESIS HEALTHCARE CO. EXPANDS WHOLE GENOME SEQUENCING CAPABILITIES
  • 6.13.3 VIOME LIFE SCIENCES LAUNCHES FULL BODY INTELLIGENCE TEST
• 6.14 INVESTMENT AND FUNDING SCENARIO

7 PRECISION NUTRITION MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 METABOLOMICS
  • 7.2.1 RISING NEED FOR METABOLIC HEALTH SOLUTIONS IN CHRONIC DISEASE CONTROL TO DRIVE MARKET
• 7.3 GENOMICS
  • 7.3.1 FALLING GENETIC TESTING COSTS AND RISING PUBLIC INTEREST IN NUTRIGENOMICS TO DRIVE DEMAND
• 7.4 TRANSCRIPTOMICS
  • 7.4.1 SEQUENCING ADVANCES PROPEL RNA RESEARCH AND BOOST TRANSCRIPTOMICS IN PRECISION NUTRITION
• 7.5 PROTEOMICS
  • 7.5.1 ADVANCEMENTS IN MASS SPECTROMETRY AND BIOINFORMATICS TO FUEL DEMAND
• 7.6 OTHER TECHNOLOGIES

8 PRECISION NUTRITION MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 WEIGHT MANAGEMENT
  • 8.2.1 RISING RATES OF OVERWEIGHT AND OBESITY TO DRIVE MARKET
• 8.3 DISEASE MANAGEMENT
  • 8.3.1 SURGE IN CHRONIC DISEASE RATES AND BREAKTHROUGHS IN GENOMICS AND BIOTECH TO DRIVE MARKET
• 8.4 SPORTS NUTRITION
  • 8.4.1 GROWING FOCUS ON PERSONALIZED HEALTH ASSESSMENTS AND ADJUSTMENTS TO DRIVE DEMAND
• 8.5 GENERAL HEALTH & WELLNESS
  • 8.5.1 GROWING EMPHASIS ON PERSONALIZED DIETARY GUIDANCE FOR LONG-TERM HEALTH TO DRIVE DEMAND

9 PRECISION NUTRITION MARKET, BY SERVICE TYPE

• 9.1 INTRODUCTION
• 9.2 GENOMICS & MULTI-OMICS ANALYSIS SERVICES
  • 9.2.1 INCREASING DEMAND FOR GENOMIC-BASED DIETARY SERVICES TO DRIVE MARKET
• 9.3 PERSONALIZED PLANS & SUBSCRIPTION SERVICES
  • 9.3.1 NEED FOR CONVENIENCE AND CUSTOMIZED WELLNESS PROGRAMS TO DRIVE DEMAND
• 9.4 CONSULTATION SERVICES
  • 9.4.1 INCREASING DEMAND FOR EXPERT GUIDANCE ON SPECIFIC HEALTH CONDITIONS TO DRIVE MARKET
• 9.5 DIGITAL PLATFORMS & SOLUTIONS
  • 9.5.1 INNOVATIONS IN AI TECHNOLOGY AND WIDESPREAD ADOPTION OF WEARABLE DEVICES TO DRIVE MARKET
• 9.6 INSTITUTIONAL & WELLNESS PROGRAMS
  • 9.6.1 SURGE IN HEALTHCARE EXPENDITURES AND DEMAND FOR CREDIBLE, EVIDENCE-BASED WELLNESS PROGRAMS TO DRIVE MARKET

10 PRECISION NUTRITION MARKET, BY END USE

• 10.1 INTRODUCTION
• 10.2 HEALTHCARE PROVIDERS
  • 10.2.1 HEALTHCARE PROVIDERS PLAY SIGNIFICANT ROLE IN ADVANCING PRECISION MEDICINE
• 10.3 RESEARCH INSTITUTES
  • 10.3.1 DEMAND FOR SAFE, EFFECTIVE, AND EVIDENCE-BASED PERSONALIZED NUTRITION SOLUTIONS TO DRIVE MARKET
• 10.4 DIETARY SUPPLEMENT MANUFACTURERS
  • 10.4.1 PRECISION NUTRITION TREND WITH TRANSPARENT, EVIDENCE-BACKED FORMULATIONS TO BOOST MARKET
• 10.5 FITNESS & WELLNESS COMPANIES
  • 10.5.1 GROWING PREFERENCE FOR HIGH-LEVEL PERSONALIZATION IN FITNESS AND NUTRITION TO DRIVE MARKET
• 10.6 DIRECT-TO-CONSUMERS
  • 10.6.1 RISING POPULARITY OF GENETIC TESTING KITS, HOME HEALTH ASSESSMENTS, AND NUTRITION-TRACKING APPS TO DRIVE MARKET

11 PRECISION NUTRITION MARKET, BY SUPPLEMENT

• 11.1 INTRODUCTION
• 11.2 VITAMINS
  • 11.2.1 RISING AGING POPULATION TO DRIVE DEMAND
• 11.3 MINERALS
  • 11.3.1 RISING CASES OF OSTEOPOROSIS AND IRON DEFICIENCY TO DRIVE MARKET
• 11.4 PROBIOTICS
  • 11.4.1 INCREASING POPULARITY OF DIGESTIVE HEALTH SUPPLEMENTS TO INCREASE DEMAND
• 11.5 HERBAL SUPPLEMENTS
  • 11.5.1 INCREASING FOCUS ON PERSONALIZED HERBAL SOLUTIONS FOR GENERAL HEALTH & WELLNESS TO EXPAND MARKET
• 11.6 PROTEIN SUPPLEMENTS
  • 11.6.1 RISING DEMAND FOR PLANT-BASED DIETS TO DRIVE DEMAND
• 11.7 AMINO ACIDS
  • 11.7.1 GROWING USE IN SPORTS NUTRITION TO INCREASE DEMAND
• 11.8 ENZYMES
  • 11.8.1 NUTRIENT ABSORPTION BENEFITS TO DRIVE DEMAND
• 11.9 OTHER SUPPLEMENTS

12 PRECISION NUTRITION MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 US
    • 12.2.1.1 Advancements in AI, availability of rich datasets, and growing public interest in personalized nutrition to drive market
  • 12.2.2 CANADA
    • 12.2.2.1 Supportive healthcare policies and growing focus on long-term health to drive market
  • 12.2.3 MEXICO
    • 12.2.3.1 Increasing public health concerns, rising wellness priorities, and innovative tech integration to drive market
• 12.3 EUROPE
  • 12.3.1 GERMANY
    • 12.3.1.1 Strong commitment to AI and digital health to expand market
  • 12.3.2 FRANCE
    • 12.3.2.1 Increasing launch of new nutraceuticals and functional foods to drive market
  • 12.3.3 UK
    • 12.3.3.1 Presence of key industry players and rising focus on personalized dietary solutions to drive market
  • 12.3.4 ITALY
    • 12.3.4.1 Increased investment in personalized health solutions to fuel market growth
  • 12.3.5 SPAIN
    • 12.3.5.1 Rising health awareness and technological advancements to drive market
  • 12.3.6 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 CHINA
    • 12.4.1.1 Growing focus on personalized nutritional strategies and national health policy goals to drive market
  • 12.4.2 INDIA
    • 12.4.2.1 Surge in cardiovascular disease deaths to drive market
  • 12.4.3 JAPAN
    • 12.4.3.1 Rising aging population and increased health risks to drive market
  • 12.4.4 SINGAPORE
    • 12.4.4.1 National Precision Medicine Programme to drive market
  • 12.4.5 AUSTRALIA & NEW ZEALAND
    • 12.4.5.1 Research innovations and increasing demand for personalized health solutions to fuel market
  • 12.4.6 INDONESIA
    • 12.4.6.1 Government initiatives to expand genomic technology to drive market
  • 12.4.7 MALAYSIA
    • 12.4.7.1 Increasing awareness of precision nutrition among youth to fuel market
  • 12.4.8 THAILAND
    • 12.4.8.1 Advancements in genomics ecosystem to drive market
  • 12.4.9 VIETNAM
    • 12.4.9.1 Collaborations in genomics technology development to drive market
  • 12.4.10 REST OF ASIA PACIFIC
• 12.5 SOUTH AMERICA
  • 12.5.1 BRAZIL
    • 12.5.1.1 Government focus on tackling malnutrition and obesity through better nutrition to drive market
  • 12.5.2 ARGENTINA
    • 12.5.2.1 Focus on managing non-communicable diseases to accelerate market growth
  • 12.5.3 REST OF SOUTH AMERICA
• 12.6 REST OF THE WORLD
  • 12.6.1 AFRICA
    • 12.6.1.1 Enhanced healthcare infrastructure and cooperation with global entities to drive market
  • 12.6.2 MIDDLE EAST
    • 12.6.2.1 Advancements in genomics, personalized healthcare, and digital health technologies to accelerate market growth

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
• 13.3 REVENUE ANALYSIS, 2021-2023
• 13.4 MARKET SHARE ANALYSIS, 2023
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Service type footprint
    • 13.5.5.4 Technology footprint
    • 13.5.5.5 Application footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 13.6.5.1 Detailed list of key startups/SMEs
    • 13.6.5.2 Competitive benchmarking of key startups/SMEs
• 13.7 COMPANY VALUATION AND FINANCIAL METRICS
• 13.8 PRODUCT COMPARISON
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS
  • 13.9.4 OTHERS
• 13.10 KEY PLAYER STRENGTH ANALYSIS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 PRENETICS GLOBAL LIMITED
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products/Solutions/Services offered
    • 14.1.1.3 MnM view
      • 14.1.1.3.1 Key strengths
      • 14.1.1.3.2 Strategic choices
      • 14.1.1.3.3 Weaknesses and competitive threats
  • 14.1.2 VIOME LIFE SCIENCES, INC.
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products/Solutions/Services offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches
      • 14.1.2.3.2 Deals
      • 14.1.2.3.3 Others
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Key strengths
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 ZOE LIMITED
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products/Solutions/Services offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product launches
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Key strengths
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses and competitive threats
  • 14.1.4 DAYTWO INC.
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products/Solutions/Services offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Others
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Key strengths
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses and competitive threats
  • 14.1.5 23ANDME, INC.
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products/Solutions/Services offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Product launches
      • 14.1.5.3.2 Deals
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Key strengths
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses and competitive threats
  • 14.1.6 THORNE
    • 14.1.6.1 Business overview
    • 14.1.6.2 Product/Solutions/Services offered
    • 14.1.6.3 MnM view
  • 14.1.7 GENESIS HEALTHCARE CO.
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products/Solutions/Services offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product launches
      • 14.1.7.3.2 Deals
    • 14.1.7.4 MnM view
  • 14.1.8 AJINOMOTO CO., INC.
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products/Solutions/Services offered
    • 14.1.8.3 MnM view
  • 14.1.9 AMILI
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products/Solutions/Services offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Others
    • 14.1.9.4 MnM view
  • 14.1.10 DNALYSIS
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products/Solutions/Services offered
    • 14.1.10.3 MnM view
  • 14.1.11 MYDNA LIFE AUSTRALIA PTY LTD.
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products/Solutions/Services offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Deals
    • 14.1.11.4 MnM view
  • 14.1.12 NUTRIGENOMIX
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products/Solutions/Services offered
    • 14.1.12.3 MnM view
  • 14.1.13 SELFDECODE
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products/Solutions/Services offered
    • 14.1.13.3 Recent developments
      • 14.1.13.3.1 Deals
    • 14.1.13.4 MnM view
  • 14.1.14 XCODE LIFE
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products/Solutions/Services offered
    • 14.1.14.3 Recent developments
      • 14.1.14.3.1 Product launches
    • 14.1.14.4 MnM view
  • 14.1.15 GENEQUEST INC.
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products/Solutions/Services offered
    • 14.1.15.3 Recent developments
      • 14.1.15.3.1 Product launches
      • 14.1.15.3.2 Deals
    • 14.1.15.4 MnM view
• 14.2 OTHER PLAYERS
  • 14.2.1 METAGEN, INC.
    • 14.2.1.1 Business overview
    • 14.2.1.2 Products/Solutions/Services offered
    • 14.2.1.3 MnM view
  • 14.2.2 HOLIFYA S.R.L.
    • 14.2.2.1 Business overview
    • 14.2.2.2 Products/Solutions/Services offered
    • 14.2.2.3 Recent developments
      • 14.2.2.3.1 Others
    • 14.2.2.4 MnM view
  • 14.2.3 LIFENOME INC.
    • 14.2.3.1 Business overview
    • 14.2.3.2 Products/Solutions/Services offered
    • 14.2.3.3 Recent developments
      • 14.2.3.3.1 Product launches
    • 14.2.3.4 MnM view
  • 14.2.4 GENOPALATE INC.
    • 14.2.4.1 Business overview
    • 14.2.4.2 Product/Solutions/Services offered
    • 14.2.4.3 Recent developments
      • 14.2.4.3.1 Product launches
      • 14.2.4.3.2 Others
    • 14.2.4.4 MnM view
  • 14.2.5 SUN GENOMICS
    • 14.2.5.1 Business overview
    • 14.2.5.2 Products/Solutions/Services offered
    • 14.2.5.3 Recent developments
      • 14.2.5.3.1 Product launches
      • 14.2.5.3.2 Deals
      • 14.2.5.3.3 Expansions
    • 14.2.5.4 MnM view
  • 14.2.6 GX SCIENCES, LLC
    • 14.2.6.1 Business overview
    • 14.2.6.2 Products/Solutions/Services offered
    • 14.2.6.3 MnM view
  • 14.2.7 SEGTERRA, INC.
    • 14.2.7.1 Business overview
    • 14.2.7.2 Products/Solutions/Services offered
    • 14.2.7.3 Recent developments
      • 14.2.7.3.1 Product launches
      • 14.2.7.3.2 Others
    • 14.2.7.4 MnM view
  • 14.2.8 NUTRISENSE
    • 14.2.8.1 Business overview
    • 14.2.8.2 Products/Solutions/Services offered
    • 14.2.8.3 MnM view
  • 14.2.9 CENTURY GENOMICS LIMITED
    • 14.2.9.1 Business overview
    • 14.2.9.2 Products/Solutions/Services offered
    • 14.2.9.3 MnM view
  • 14.2.10 GENEUSDNA
    • 14.2.10.1 Business overview
    • 14.2.10.2 Products/Solutions/Services offered
    • 14.2.10.3 MnM view

15 ADJACENT AND RELATED MARKETS

• 15.1 INTRODUCTION
• 15.2 LIMITATIONS
• 15.3 PERSONALIZED NUTRITION MARKET
  • 15.3.1 MARKET DEFINITION
  • 15.3.2 MARKET OVERVIEW
• 15.4 NUTRITIONAL ANALYSIS MARKET
  • 15.4.1 MARKET DEFINITION
  • 15.4.2 MARKET OVERVIEW
• 15.5 DIETARY SUPPLEMENTS MARKET
  • 15.5.1 MARKET DEFINITION
  • 15.5.2 MARKET OVERVIEW

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS